ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024
Voice-Activated Self-Monitoring Application (VoiS): Perspectives from People with Diabetes and Hypertension.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Applications of Artificial Intelligence Technologies in Nursing for Noncommunicable Chronic Diseases: A Scoping Review.Journal of nursing management · 2026Article
- Voice-Activated Self-Monitoring Application (VoiS): User Acceptance and Satisfaction in the Field.Proceedings : Annual International Computer Software and Applications Conference. COMPSAC · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
This paper describes the development and usability test processes of the voice-activated self-monitoring (VoiS) application. VoiS is an innovative, theory-driven mobile app on a smart speaker platform that supports routine and convenient self-monitoring of blood pressures, glucose levels, and health behaviors by people with coexisting diabetes and hypertension. It improves the quality of their communication with healthcare providers. The prototype of VoiS includes voice interaction with Amazon Alexa and data representation using smartphones (iOS and Android). Fourteen people with coexisting diabetes and hypertension participated in usability testing. After completing a range of tasks individually, testers participated in group interviews. We used a survey based on the Technology Acceptance Model to measure the ease of use and perceived usefulness of VoiS. All interviews were recorded and transcribed, and then common themes were extracted. Participants found VoiS to be easy to use and useful.
Indexed as
Identifiers
40417574PMC12099394What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.